
New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing. Perceptive Xontogeny Venture Fund led the round.
Source: Press Release
New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing.
New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing. Perceptive Xontogeny Venture Fund led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination